Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.
Julian G Hurdle, Raghunandan Yendapally, Dianqing Sun, Richard E Lee
文献索引:Antimicrob. Agents Chemother. 53 , 4028-31, (2009)
全文:HTML全文
摘要
The potential for reutericyclin derivatives to be used as topical antibiotics to treat staphylococcal skin infections was investigated. All reutericyclins inhibited the growth of clinical isolates of drug-resistant Staphylococcus aureus. Unlike the standard topical agent mupirocin, most reutericyclin derivatives eradicated staphylococcal biofilms. Moreover, two compounds formulated in hydrophilic petrolatum (10%, wt/wt) were efficacious in treating S. aureus superficial skin infections in mice. These data exemplify the prospect of developing reutericyclins as new topical antibiotics.
相关化合物
相关文献:
2014-12-01
[Tuberculosis (Edinb.) 94(6) , 701-7, (2015)]
2015-02-01
[PLoS Pathog. 11(2) , e1004645, (2015)]
2014-12-01
[J. Antimicrob. Chemother. 69(12) , 3199-202, (2014)]
2014-01-01
[PLoS ONE 9(4) , e93953, (2014)]
2015-02-01
[Pulm. Pharmacol. Ther. 30 , 80-6, (2015)]